|
|||||
|
|
HDAC inhibitor chidamide synergizes with venetoclax to inhibit the growth of diffuse large B-cell lymphoma via down-regulation of MYC,BCL2, and TP53 expression |
|
| Authors: | Cancan LUO Tiantian YU Ken H YOUNG Li YU |
| Institution: | 1.Department of Hematology, the Second Affiliated Hospital of Nanchang University, Nanchang 330006, China;2.Jiangxi Province Key Laboratory of Hematology, Nanchang 330006, China;3.Department of Hematopathology, Duke University School of Medicine, Duke University Medical Center, Durham, NC 27710, USA |
| Abstract: | |
| Keywords: | Diffuse large B-cell lymphoma (DLBCL) Histone deacetylase (HDAC) inhibitor Venetoclax MYC BCL2 TP53 |